Company Filing History:
3 out of 7 
1 out of 13 
1 out of 2 Years Active: 2020-2023
Title: Innovations and Contributions of Inventor David Lawrence Cutler
Introduction
David Lawrence Cutler, an accomplished inventor based in Moorestown, NJ, has made significant contributions to the field of pharmaceuticals. With a total of five patents, his work primarily focuses on developing innovative treatments for cancer and other medical conditions.
Latest Patents
One of David's latest patents is titled "Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer." This patent provides pharmaceutical combinations that are effective in treating cancer while also aiming to reduce or prevent toxicity and hypersensitivity type infusion reactions associated with intravenously administered irinotecan therapy, commonly known as Camptosar®. Another notable patent pertains to "Methods of treating and/or preventing actinic keratosis." This application discusses methods involving the administration of a therapeutically effective amount of KX-01 to treat or prevent actinic keratosis in patients in need.
Career Highlights
Throughout his career, David Lawrence Cutler has worked with reputable companies in the biopharmaceutical sector, including Athenex Hk Innovative Limited and Athenex, Inc. His dedication to innovation in the pharmaceutical industry has led to the development of pioneering products that address significant medical challenges.
Collaborations
David's work has often involved collaboration with esteemed professionals in the field. He has worked alongside Min-Fun Rudolf Kwan and Johnson Yiu-Nam Lau, contributing to advancements in pharmaceutical research and development.
Conclusion
David Lawrence Cutler's innovative spirit and commitment to improving patient outcomes are evident in his patents and professional collaborations. His work not only enhances treatment options for cancer patients but also sets a benchmark for future developments in pharmaceuticals.